Status:
UNKNOWN
The Impact of Age on Botulinum Toxin Potency in Facial Rhytides Treatment
Lead Sponsor:
St Joseph University, Beirut, Lebanon
Conditions:
Aging
Botulinum Toxin
Eligibility:
All Genders
25+ years
Phase:
NA
Brief Summary
Botulinum toxin is approved by the FDA for the treatment of facial wrinkles. Patients are usually older than 45 years and their main demand is to treat pre-existing facial wrinkles. However with the i...
Detailed Description
Botulinum toxin is approved by the FDA for the treatment of facial wrinkles. Patients are usually older than 45 years and their main demand is to treat pre-existing facial wrinkles. However with the i...
Eligibility Criteria
Inclusion
- female patients presenting to our clinic for Facial wrinkle treatment with botulinum toxin
- Must be between 25-35 years old to be included in group 1.
- Must be older than 45 to be included in groups 2 and 3.
Exclusion
- Patients with previous periorbital/forehead surgery
- Patients who plucked the upper eyebrow margin
- Patients with eyebrow tatoos
- Patients with upper face botulinum toxin injection in the past 12 months
- Patients with resorbable upper face fillers injection in the past 12 months
- Patients with previous permanent upper face fillers injection
- Pregnant patients
- Lactating patients
- Patients with preexisting neuromuscular conditions (myasthenia gravis, Eaton Lambert syndrome)
- Patients using medication that could potentiate the effect of botulinum (ex: aminoglycoside antibiotics)
- Patients with sensitivity to botulinum toxin or human albumin
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03836638
Start Date
May 1 2019
End Date
December 1 2020
Last Update
February 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hotel Dieu De France
Beirut, Aschrafieh, Lebanon, 00961